ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report)’s share price traded up 3.5% during trading on Friday . The stock traded as high as $1.95 and last traded at $1.91. 528,534 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 3,818,147 shares. The stock had previously closed at $1.84. […]
ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) shot up 3.5% during mid-day trading on Friday . The company traded as high as $1.95 and last traded at $1.91. 528,534 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 3,818,147 shares. The stock had previously closed at $1.84. Analyst […]
ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report)’s share price was down 4.9% during trading on Monday . The stock traded as low as $1.74 and last traded at $1.74. Approximately 71,328 shares traded hands during trading, a decline of 98% from the average daily volume of 3,862,941 shares. The stock had previously closed at $1.83. […]
Fishman Jay A Ltd. MI increased its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 387.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 112,000 shares of the company’s stock after purchasing an additional 89,000 shares […]
ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $2.04, but opened at $1.93. ImmunityBio shares last traded at $1.96, with a volume of 335,514 shares traded. Wall Street Analyst Weigh In Separately, Piper Sandler downgraded ImmunityBio from an “overweight” […]